Abstract
Recently, we cloned a novel sulfatase domain-containing downregulated gene, HSulf-1, which modulates heparin-binding growth factor signaling in ovarian cancer. Based on the pilot data showing the loss of HSulf-1 in head and neck squamous cell carcinoma cell lines (SCCHN), we sought to employ SCCHN as a model to define the role of HSulf-1 in the molecular regulation of tumorigenecity. Three SCCHN lines (012SCC, WMMSCC, and 015SCC) had no detectable HSulf-1 mRNA. Clonal lines of HSulf-1-expressing 012SCC attenuated the activation of ERK/mitogen-activated protein kinase (MAPK) signaling mediated by fibroblast growth factor (FGF-2) and both ERK/MAPK and Akt signaling mediated by hepatocyte growth factor (HGF). Consistent with this downregulation, phosphorylation of HGF receptor, c-Met, which is frequently overexpressed in SCCHN, was also attenuated in HSulf-1 clonal 012SCC cell lines. HGF markedly enhanced the motility and migration of vector-transfected cells in a transwell invasion chamber. However, HGF-mediated motility and invasion was attenuated in HSulf-1 clonal 012SCC cell lines. In addition, transfected cells displayed significant growth inhibition concomitant with a decrease in mitogenecity, as measured by thymidine incorporation and increased sensitivity to staurosporine- and cisplatin-induced apoptosis. These data suggest that HSulf-1 normally functions as a negative regulator in cell growth and loss of HSulf-1 in SCCHN potentiates growth factor signaling, enhances motility, invasiveness and inhibits stress-induced apoptosis, with a resulting increase in tumorigenecity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Betz CS, Lai JP, Xiang W, Janda P, Heinrich P, Stepp H, Baumgartner R and Leunig A . (2002). Photochem. Photobiol. Sci., 1, 315–319.
Bhalla US, Ram PT and Iyengar R . (2002). Science, 297, 1018–1023.
Bonni A, Brunet A, West AE, Datta SR, Takasu MA and Greenberg ME . (1999). Science, 286, 1358–1362.
Chien J and Shah GV . (2001). Int. J. Cancer, 91, 46–54.
Chikamatsu K, Reichert TE, Kashii Y, Saito T, Kawashiri S, Yamamoto E and Whiteside TL . (1999). Int. J. Cancer, 82, 532–537.
Cortesina GMT, Galeazzi E, Olivero M, De Stefani A, Bussi M, Valente G, Comoglio PM and Di Renzo MF . (2000). Int. J. Cancer, 89, 286–292.
Delehedde M, Lyon M, Gallagher JT, Rudland PS and Fernig DG . (2002). Biochem. J., 366, 235–244.
Dent P and Grant S . (2001). Clin. Cancer Res., 7, 775–783.
Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC and Van Waes C . (2001). Cancer Res., 61, 5911–5918.
Fleigel J, Sedwick J and Kornberg LJ . (2002). Otolaryngol. Head Neck Surg., 127, 271–278.
Galeazzi E, Olivero M, Gervasio FC, De Stefani A, Valente G, Comoglio PM, Di Renzo MF and Cortesina G . (1997). Eur. Arch. Otorhinolaryngol., 254, S138–S143.
Gescher A . (2000). Crit. Rev. Oncol. Hematol., 34, 127–135.
Gleich LL and Salamone FN . (2002). Cancer Control, 9, 369–378.
Hardisson D . (2003). Eur. Arch. Otorhinolaryngol., 8, 8.
Hughes RS and Frenkel EP . (1997). Am. J. Clin. Oncol., 20, 449–461.
Jeffers MRS and Woude GF . (1996). J. Mol. Med., 74, 505–513.
Katoh M . (2002). Int. J. Oncol., 21, 1269–1273.
Khurana D, Martin EA, Kasperbauer JL, O'Malley Jr BW, Salomao DR, Chen L and Strome SE . (2001). Head Neck, 23, 899–906.
Lai J, Chien J, Staub JK, Avula R, Greene EL, Matthews TA, Smith DI, Kaufmann SH, Roberts LR and Shridhar V . (2003). J. Biol. Chem., 278, 23107–23117.
Lai JP, Tong CL, Hong C, Xiao JY, Tao ZD, Zhang Z, Tong WM and Betz CS . (2002). Laryngoscope, 112, 402–408.
Liu D, Shriver Z, Qi Y, Venkataraman G and Sasisekharan R . (2002). Semin. Thromb. Hemost., 28, 67–78.
Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M and Claesson-Welsh L . (2000). J. Biol. Chem., 275, 24653–24660.
Lyon M, Deakin JA, Mizuno K, Nakamura T and Gallagher JT . (1994). J. Biol. Chem., 269, 11216–11223.
Matsumoto KMK, Nakamura T and Kramer RH . (1994). J. Biol. Chem., 269, 31807–31813.
Modjtahedi H and Dean C . (1995). Biochem. Biophys. Res. Commun., 207, 389–397.
Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S and Rosen SD . (2002). J. Biol. Chem., 277, 49175–49185.
Riedel F, Gotte K, Bergler W, Rojas W and Hormann K . (2000). Head Neck, 22, 183–189.
Riedel F, Gotte K, Li M, Hormann K and Grandis JR . (2002). Int. J. Oncol., 21, 11–16.
Rubin JS, Day RM, Breckenridge D, Atabey N, Taylor WG, Stahl SJ, Wingfield PT, Kaufman JD, Schwall R and Bottaro DP . (2001). J. Biol. Chem., 276, 32977–32983.
Rong SS, Anver M, Resau JH and Woude GFV . (1994). Proc. Natl. Acad. Sci. USA, 91, 4731–4735.
Sasisekharan R, Shriver Z, Venkataraman G and Narayanasami U . (2002). Nat. Rev. Cancer, 2, 521–528.
Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J and Smith DI . (2002). Cancer Res., 62, 262–270.
Simon C, Nemechek AJ, Boyd D, O'Malley Jr BW, Goepfert H, Flaitz CM and Hicks MJ . (1998). Laryngoscope, 108, 1686–1691.
Strome SE, Kawakami K, Alejandro D, Voss S, Kasperbauer JL, Salomao D, Chen L, Maki RA and Puri RK . (2002). Clin. Cancer Res., 8, 281–286.
Vlachtsis K, Brieger J, Kim DW, Gieringer R, Hast J, Hengstler JG and Mann W . (2002). Oncol. Rep., 9, 1133–1138.
Wakulich C, Jackson-Boeters L, Daley TD and Wysocki GP . (2002). Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 93, 573–579.
Zeng Q, Chen S, You Z, Yang F, Carey TE, Saims D and Wang CY . (2002). J. Biol. Chem., 277, 25203–25208.
Acknowledgements
We thank Dr Haidong Dong for help with FACS analysis. This work was supported by Mayo Foundation (to VS) and National Institutes of Health (CA82862 to LRR), an Industry Research Scholar Award from the Foundation of Digestive Health and Nutrition (to LRR).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Lai, JP., Chien, J., Strome, S. et al. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene 23, 1439–1447 (2004). https://doi.org/10.1038/sj.onc.1207258
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207258
Keywords
This article is cited by
-
Multi-omics characterization and validation of invasiveness-related molecular features across multiple cancer types
Journal of Translational Medicine (2021)
-
Sulfatase-1 knockdown promotes in vitro and in vivo aggressive behavior of murine hepatocarcinoma Hca-P cells through up-regulation of mesothelin
Journal of Cell Communication and Signaling (2018)
-
Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer
Scientific Reports (2017)
-
Changes in composition and sulfation patterns of glycoaminoglycans in renal cell carcinoma
Glycoconjugate Journal (2016)
-
Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinoma
Molecular Cancer (2015)